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Nephrotic syndrome (NS) is a common disorder of childhood (common in the age group of 2–8 years) which results in proteinuria and hypoproteinemia. NS 
remains the most common manifestation of glomerular disease 
in childhood [1]. Global incidence of NS is reported to be 20–40 
per million populations; whereas in the Indian subcontinent, it 
is estimated to be 90–100 per million populations [1]. Minimal 
change nephropathy is the most common cause of NS in children. 
Hypotheses on the pathogenesis of the syndrome have evolved 
from the concepts of “immune dysregulation,” “increased 
glomerular permeability,” and “podocytopathy” [1–4].
Clinically, NS is categorized into the first attack of NS, 
infrequently relapsing nephrotic syndrome (IFRNS) and 
frequently relapsing nephrotic syndrome (FRNS) on the basis of 
number of relapses in past 6–12 months of the disease [3]. The 
major cause of Vitamin D deficiency in children with NS is due to 
loss of both, Vitamin D binding protein and 25-Hydroxyvitamin 
D (25-(OH) D) in the urine, secondary to proteinuria. Vitamin D 
deficiency in India is further aggravated by nutritional factors, 
sunlight (increased melanin pigment preventing absorption), 
and cultural influences [5]. Deficiency in 25(OH) D may lead 
to hypocalcemia, hyperparathyroidism, and diminished bone 
mineral density/content [3].
When the 25(OH) D is low, plasma calcium is maintained by 
increased osteoclastic activity, reducing the mineral content of the 
bones. Complicating impact of Vitamin D deficiency on the bones 
in children with NS is the repeated exposure to glucocorticoids [1]. 
In studies of pediatric patients with primary or secondary NS, 25 
(OH) Vitamin D deficiency ranges from 20–100% in patients 
surveyed at various stages of the disease [6–10]. It is possible 
that the low value of 25(OH)D results in low blood levels of 
other Vitamin D metabolites, such as [1,25-(OH)2D] and 24,25-
(OH)2D; a deficiency of these compounds may cause defective 
intestinal absorption of calcium (alpha) and resistance to the 
calcemic action of parathyroid hormone (PTH), resulting in 
hypocalcemia [11].
Children with NS and adult survivors of steroid-sensitive 
minimal change disease have shown decreased bone 
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mineralization and bone abnormalities. These findings have 
led to an increased interest in supplementation of calcium 
and Vitamin D in children with NS [9,12]. To the best of our 
knowledge, a single study from India (Kolkata) in this context 
has been conducted so far, wherein Vitamin D stores were found 
to be low 3 months after NS relapse but showed an increase with 
longer remission time. The levels were not influenced by disease 
characteristics or therapy. The effect of low 25(OH) D levels on 
the disease course in patients with NS needs to be evaluated [13]. 
Hence, we conducted this study to determine the prevalence of 
Vitamin D deficiency among children with idiopathic NS during 
the remission phase.
MATERIALS AND METHODS
A cross-sectional observational study was conducted in children 
attending pediatric nephrology clinic in department of pediatrics 
at tertiary care hospital in Vadodara from April 2016 to November 
2016. The study was approved by Scientific Review Committee 
and Institutional Ethics Committee on Human Research of the 
hospital. All cases of NS either newly detected or in remission 
phase were enrolled in the study. All children in the age group 
of 2 years–12 years with NS of duration 1 month at the time of 
remission and not more than 3 months were included. Patients 
treated with Vitamin D supplements or medications which are 
known to cause Vitamin D deficiencies or affect its metabolism 
and children with secondary causes of NS, for example, SLE, 
malaria, drugs, and others were excluded.
All the children had received prednisolone (2 mg/kg) daily 
as a gold standard treatment. In the first attack, prednisolone is 
given in the dose of 2 mg/kg for 6 weeks followed by 1.5 mg/kg 
for 6 weeks and then gradually tapered. For infrequent relapses, 
prednisolone 2 mg/kg is given daily until remission, followed by 
1.5 mg/kg on alternate days for 4 weeks. In children with FRNS, 
prednisolone was given 2 mg/kg daily until remission, followed 
by 1.5 mg/kg on alternate days for 4 weeks followed by 0.5–
0.75 mg/kg on alternate days for 9–18 months.
To confirm the remission status of child, spot urine albumin 
test was performed using sulfosalicylic acid test on the urine 
sample collected during the visit [14]. Child having trace or 
nil urine albumins on two consecutive visits 1 week apart 
were taken to be in remission. After taking informed written 
consent, blood sample was collected in plain Vacutainer 
and sent for estimation of serum Vitamin 25(HO)D levels 
by chemiluminescence method [15]. Vitamin D deficiency 
was categorized as 25 (OH) D levels <20ng/ml. It was 
further categorized as insufficiency (16–20 ng ml), moderate 
deficiency (5–15 ng/ml), and severe deficiency (<5 ng ml). 
No, follow-up samples were taken.
The obtained data were entered into MS Office Excel in 
a password protected file, and the same was analyzed using 
MedcalC version 12.5.0.0 (Trial version). Data being non-normally 
distributed, Vitamin D levels were reported in the form of median 
and. Statistical analysis was done to see the difference in Vitamin 
D levels across the NS, FRNS, and IFRNS groups using Kruskal–
Wallis test. p-value of 0.05 was considered statistically significant.
RESULTS
During the study period, 34 patients were enrolled; of which, 19 
were males (55.9%) and 15 females (44.1%). The mean age was 
5.7±2.7 years (95% confidence interval: 4.79–6.68), and the range 
was 2–12 years. Vitamin D deficiency was seen in 28 of 34 patients 
(82%). 16 patients (47%) had severe deficiency, seven (20%) had 
mild to moderate deficiency, and five (14.7%) had insufficient 
levels of Vitamin D. Normal levels of Vitamin D were seen in only 
6 (14%) patients (Table 1). There was no significant difference in 
Vitamin D levels among the males and females (p=0.89).
Among the 34 children included in the study, 14 had first 
attack of NS while 10 each had FRNS and IFRNS. There was no 
significant difference in the Vitamin D deficiency among subtypes 
of the NS (Chi-square 0.769, p=0.68). Median (interquartile range 
[IQR]) days of remission were 41 days (range 30–59 days). There 
was no significant correlation between age and Vitamin D levels 
(p=0.58) or days of remission and Vitamin D levels (p=0.34).
Children with first attack of NS had a median (IQR) Vitamin D 
level of 8.17 (2.9–28) ng/ml, those with IFRNS had a median 
(IQR) Vitamin D level of 6.8 (2.9–33) ng/ml, while children with 
FRNS had the lowest median (IQR) Vitamin D level of 5.3 (2.9–
16) ng/ml (Fig. 1). Although all the three groups showed decreased 
levels of Vitamin D, Kruskal–Wallis one-way analysis of variance 
did not show any statistically significant difference in the Vitamin 
D levels across the three groups (Kruskal–Wallis 4.89 p=0.08).
DISCUSSION
Studies with evidence on the prevalence of Vitamin D deficiency 
and its relation to NS are only a few [12]. To the best of our 
knowledge, only one case–control study has been carried out to 
explore Vitamin D deficiency in pediatric patients with idiopathic 
NS in remission in the Indian context [13]. We, therefore, believe 
that our report may contribute useful additional data to the limited 
Table 1: Vitamin D deficiency among the children with nephritic syndrome
Vitamin D level (ng/ml) First attack (n=14) FR (n=10) IFR (n=10) Total n=34 (%)
<5 (Severe) 6 5 5 16 (47)
5–15 (Moderate) 3 2 2 7 (20.5)
16–20 (Insufficiency) 1 3 1 5 (14.7)
More than 21 (Adequate) 4 0 2 6 (17.64)
Chi-square is 0.769, DF=2, P=0.68
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available evidence base. The specific role of Vitamin D in NS 
should be identified so that an effective and early treatment 
modality can be achieved [14]. This study showed a high 
prevalence of Vitamin D deficiency, with 82% NS patients having 
25 (OH) D levels of <20 ng/ml which is higher than the study by 
Banerjee et al.[13]. 
Almost half of the pediatric patients in this study group had 
severe Vitamin D deficiency; this was almost equally distributed 
among the first attack, FRNS, and IFRNS patients. A case–control 
study by Banerjee et al. showed a positive correlation with months 
elapsed since last NS relapse (r s=+0.4, p=0.012) [13]. However, 
this was not the case in our study group. A small sample size could 
be one of the reasons for these findings, which, however, could 
be validated by a follow-up the study of the same patient cohort.
In another study done by Nielsen et al. at Denmark, 13 of 
the 14 children (prospective study) with the first episode of NS 
before treatment with glucocorticoids had 25(OH) D deficiency 
including 12 (86%), who had moderate or severe Vitamin D 
deficiency [16]. However, a very small sample size would make 
it difficult to compare the Vitamin D deficiency levels across the 
different groups.
Median Vitamin D levels in the study by Banerjee et al. 
were lower in NS patients with remission period <3 months but 
similar to that of controls in patients in remission for >3 months 
(median 14.23 [interquartile range 12.19–17.63] vs. 19.75 
[14.04–28.38] ng/ml, respectively; p=0.039) [13]. In our study, 
the median levels of Vitamin D for patients with the first attack of 
NS were higher than FRNS and IFRNS, though not statistically 
significant. Biochemical parameters such as serum calcium, 
PTH, and phosphorus levels could not be assessed, which was the 
limitation of this study.
This study can be taken forward as a prospective study with 
monitoring of Vitamin D levels three monthly. Furthermore, a 
case–control study with and without Vitamin D supplementation 
to study the effect of the same in these patients, so as to set up 
departmental policy can be undertaken. After this study, we have 
started supplementing all the children with NS with 400–600 IU 
per day Vitamin D along with calcium. We recommend more 
multicenter case–control studies with larger sample size with 
longer follow-up to make an ideal protocol for estimation and 
supplementation of Vitamin D in idiopathic NS to prevent bone 
diseases in adolescent and childhood NS survivor.
CONCLUSION
Decreased Vitamin D levels were observed in all the three groups, 
i.e. first attack NS, FRNS, and IFRNS of our study population, 
lowest being in the children with frequent relapses of NS. An ideal 
protocol can be made where the estimation of Vitamin D is done 
before starting steroid treatment for NS and supplementation of 
Vitamin D started at the earliest while assessing the deficiency 
during the course of the disease and remission.
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